Cakiroglu Basri, Hazar Aydin Ismet, Sinanoglu Orhun, Arda Ersan, Ekici Sinan
Hisar Intercontinental Hospital, Department of Urology, Istanbul.
Arch Ital Urol Androl. 2017 Mar 31;89(1):31-33. doi: 10.4081/aiua.2017.1.31.
To compare the functional outcomes and retrograde ejaculation (RE) after transurethral incision of the prostate (TUIP) or silodosin in bladder outlet obstruction (BOO) secondary to a small prostate.
Prospectively collected data from December 2011 through December 2014 of 192 LUTS patients having fertility concerns with prostate volume smaller than 40 ml receiving either TUIP or silodosin treatment were prospectively reviewed. The treatment outcomes were evaluated and compared.
TUIP was performed in 96 cases and silodosin 8 mg was prescribed in 96 cases. At 12th months after TUIP or continuous silodosin treatment, the decrease in mean International Prostate Symptom Score (IPSS) and postvoiding residual urine (PVR) and the improvement of mean maximal flow rate (Qmax) were significant (p = 0.000). The improvement in IPPS and Qmax was significantly higher in TUIP group compared to silodosin group (p = 0.005, p = 0.000) with a lower rate of retrograde ejaculation (RE) in TUIP group. (11/96 vs 33/96) (p = 0.000) Conclusions: Both TUIP and silodosin ensures comparable improvement in PVR, IPSS and Qmax with a lower rate of RE on the TUIP group in prostates weighing less than 40 grams suggesting that TUIP is a better choice in younger patiens seeking preservation of ejaculation with fertility concerns.
比较经尿道前列腺切开术(TUIP)与使用西洛多辛治疗小前列腺继发膀胱出口梗阻(BOO)后的功能结局及逆行射精(RE)情况。
对2011年12月至2014年12月前瞻性收集的192例有生育顾虑、前列腺体积小于40 ml且接受TUIP或西洛多辛治疗的下尿路症状(LUTS)患者的数据进行前瞻性回顾。对治疗结局进行评估和比较。
96例行TUIP,96例服用8 mg西洛多辛。在TUIP或持续使用西洛多辛治疗12个月后,平均国际前列腺症状评分(IPSS)及排尿后残余尿量(PVR)降低,平均最大尿流率(Qmax)改善,差异有统计学意义(p = 0.000)。TUIP组IPSS及Qmax的改善显著高于西洛多辛组(p = 0.005,p = 0.000),且TUIP组逆行射精(RE)发生率较低(11/96 vs 33/96)(p = 0.000)。结论:对于前列腺重量小于40克的患者,TUIP和西洛多辛均可使PVR、IPSS及Qmax得到类似改善,且TUIP组RE发生率较低,这表明对于有生育顾虑且寻求保留射精功能的年轻患者,TUIP是更好的选择。